Wannan shafin yana aiwatar da ayyuka na asali kuma bai shirya don amfanin marasa lafiya ba tukuna.
Don bayani kawai — ba shawarar likita ba ne
Yaya tsananinsa?
Haɗarin mutuwa
Eh
Allurar rigakafi tana nan?
Lokacin zuwa alamomi
Ƙasashen da abin ya shafa
Annobar da ke gudana
Ka tabbatar da allurar karfafawa ta diphtheria na yanzu (Td/Tdap kowace shekara 10). Ba ya da yawa a cikin al'ummomin da suka yi allurar rigakafi amma har yanzu yana yaduwa a sassan Afirka, Kudancin Asiya, da tsoffin jihohin Soviet. Ka nemi taimako nan take don ciwon makogwaro mai tsanani tare da fatar launin toka a lokacin tafiya zuwa yankunan da cutar ke yaduwa.
Makogwaro (diphtheria) cuta ce mai haɗari da ƙwayar Corynebacterium diphtheriae ke haifarwa. Tana haifar da kauri mai kauri a maƙogwaro wanda zai iya toshe hanyar iska.
Alamomi | Yawan faruwa | Tsanani | Farawa |
|---|---|---|---|
| Wahalar haɗiya | 75% | Matsakaici | Farkon cuta |
| Zazzabi | 70% | Dan kadan | Farkon cuta |
| Rashin jin daɗi | 85% | Dan kadan | Farkon cuta |
| Ciwon maƙogwaro | 90% | Matsakaici | Farkon cuta |
| Ciwon kai | 50% | Dan kadan | Farkon cuta |
| Rashin son ci | 65% | Dan kadan | Farkon cuta |
| Tashin zuciya | 30% | Dan kadan | Farkon cuta |
| Toshewar hanci | 8% | Dan kadan | Farkon cuta |
| Kumburin jiki | 25% | Matsakaici | Kololuwar cuta |
| Ƙarancin numfashi | 25% | Mai tsanani | Kololuwar cuta |
| Kumburin ƙwayoyin lymph | 70% | Matsakaici | Kololuwar cuta |
| Tari | 40% | Dan kadan | Kololuwar cuta |
| Amai | 15% | Dan kadan | Kololuwar cuta |
| Raguwar matsin jini | 10% | Mai tsanani | Ƙarshen cuta |
| Shanyewar gaɓoɓi | 5% | Mai tsanani | Ƙarshen cuta |
| Saurin bugun zuciya | 20% | Matsakaici | Ƙarshen cuta |
| Duhu a gani | 8% | Dan kadan | Ƙarshen cuta |
| Jin ƙaiƙayi/cizon allura | 10% | Dan kadan | Ƙarshen cuta |
| Gajiya | 80% | Dan kadan | Kowane lokaci |
| Gyambon fata | 20% | Matsakaici | Kowane lokaci |
Serious bacterial infection affecting the mucous membranes of the throat and nose.
Diphtheria cutar kwayoyin cuta ce da Corynebacterium diphtheriae mai samar da guba (toxin) ke haddasa ta. Tana haifar da wani farin/toka-toka (membrane) mai mannewa a cikin makogwaro da na'ura ta numfashi. Matsaloli masu hatsari sun hada da kumburin zuciya saboda guba (toxic myocarditis) — wanda shine babban sanadin mutuwa — da lalacewar jijiyoyi (polyneuropathy).
Barkewar cuta a Najeriya 2022-2023: Najeriya ta fuskanci babbar barkewar diphtheria da ta fara a Kano a watan Mayun 2022 kuma ta bazu zuwa fiye da jihohi 20. NCDC ta tabbatar da fiye da shari'o'i 17,000 da ake zargi tare da fiye da mutuwar 600. Wannan ita ce mafi girmar barkewar diphtheria a tarihin Najeriya na baya-bayan nan. Dalilai sun hada da: karancin rigakafin yara na yau da kullum (DPT3 coverage ~57%), cunkoson jama'a a birane, da rashin isassun kayan aikin lafiya.
Barkewar ta fi shafar yara 'yan shekaru 5–14 da ba a yi musu allurar rigakafi ba a Arewacin Najeriya (Kano, Katsina, Yobe, Borno, Bauchi). NCDC da NPHCDA sun gudanar da yakin neman rigakafin gaggawa. Cuta ce da dole a bayar da rahotonta nan take.
GAGGAWA — a nemi likita nan take:
Farin/toka-toka (membrane) a makogwaro
Muryar sautin karfe (stridor) ko wahalar numfashi
"Wuyan bijimi" (bull neck) — kumburin wuya
Rashin bugun zuciya na daidai (arrhythmia) ko ciwo a kirji
A nemi antitoxin nan take — kowane minti yana da muhimmanci!
Alamomi da alamu mafi yawa
Lokacin kwanciyar cuta: Kwanaki 2–5
Diphtheria na makogwaro (pharyngeal — mafi yawa):
Ciwon makogwaro mai matsakaici
Dan zazzabi (37.5–38.5°C)
Farin/toka-toka (greyish-white membrane) a kan tonsils/pharynx — mai mannewa sosai, yana zubar da jini idan aka yi kokarin cirewa
Kumburin glandin lymph a wuya — "wuyan bijimi" (bull neck)
Mummunan wari a baki
Muryar hanci (nasal voice)
Diphtheria na na'ura ta numfashi (laryngeal):
Muryar sautin karfe (stridor/croup)
Wahalar numfashi — gaggawa
Toshewar hanyar numfashi — na iya kashe cikin sa'o'i
Diphtheria na fata (cutaneous):
Matsaloli na guba (toxic complications — za su iya bayyana makonni bayan cutar ta warke):
Kumburin zuciya (toxic myocarditis): matsalar da ta fi kashe mutane, tana iya bayyana kwanaki 10–14 bayan cutar
Lalacewar jijiyoyi (polyneuropathy): gurguwar muƙamuƙi, wahalar hadiya, raunin ƙafafu
Rashin aikin koda (nephrotoxicity)
Sanin alamomi shine mataki na farko don amsa cikin sauri.
Matakan cutar diphtheria (na maƙogwaro/tonsil):
Bayani: Cutar diphtheria na fata (ƙurar fata) galibi mai sauƙi ce tare da ƙarancin gubar jiki amma tana zama wurin ajiyar ƙwayoyin cuta.
Yadda ake gano wannan cutar
Ana fara magani kafin sakamakon gwaji — kada a jira!
Binciken asibiti: membrane mai toka-toka a makogwaro a cikin yaro da ba a yi masa allura ba yana da isasshen zargin diphtheria
Swab daga karkashin membrane don culture a kan Löffler's medium ko tellurite agar
PCR don gano kwayar cuta da tox gene
Elek test don tabbatar da samar da guba (toxigenicity)
A Najeriya: a bayar da rahoto nan take ga NCDC ta hanyar IDSR — case-based surveillance
Hanyoyin magani da ake da su
Gaggawa — kowane minti yana da muhimmanci:
Diphtheria Antitoxin (DAT) IV nan take — kafin sakamakon gwajin dakin gwaje-gwaje! Adadin ya danganta da tsananin cuta (20,000–120,000 IU). Ana buƙatar gwajin sensitivity kafin bayarwa.
Erythromycin 14 kwanaki ko Penicillin G don kashe kwayar cutar
Kulawar ICU
Sa ido na zuciya (cardiac monitoring) na yau da kullum — ECG kowace rana na aƙalla mako 2
Tracheostomy idan hanyar numfashi ta toshe
A lokacin barkewar cuta a Najeriya 2022-2023: karancin DAT ya kasance babban kalubale — NCDC ta nemi taimako daga WHO da kasashen duniya
Rigakafi bayan magani: Dole a yi wa mai cuta allurar rigakafi yayin warwarewa saboda cutar ba ta ba da cikakkiyar kariya ta dabi'a.
Yawancin lokuta ana magance su yadda ya kamata tare da gano cutar da wuri.
Yadda za ka kare kanka
Rigakafi — matakin da ya fi muhimmanci:
Allurar DPT/Pentavalent: A cikin jadawalin NPHCDA — a makonni 6, 10, da 14 na rayuwa
DPT3 coverage a Najeriya: ~57% (kasa da matsakaicin duniya na 86%) — wannan ita ce babbar matsalar da ta haifar da barkewar 2022-2023
Allura ta kara karfi: Td a shekara 6 da 12 (jadawalin Najeriya — amma yawancin yara ba su samu ba)
Darasin barkewar 2022-2023:
Karin rigakafin yau da kullum (RI) shine mafita na dogon lokaci
NCDC da NPHCDA sun gudanar da yakin neman rigakafin gaggawa a jihohin da suka fi shafuwa
Bukatar da za a kara yin masa karfi: sa ido (surveillance) don gano shari'o'in da wuri
Rigakafi bayan fuskanci cutar (post-exposure prophylaxis):
Maganin rigakafin kwayoyin cuta (erythromycin 7–10 kwanaki ko penicillin) ga duk wanda ya yi mu'amala da mai cuta
Allura ta kara karfi idan ba a kammala rigakafi ba
Shirye-shirye shine mafi kyawun kariya.
Masu tafiya zuwa Najeriya:
A tabbatar an kammala rigakafin DPT/Td da kuma allura ta kara karfi idan shekaru 10 sun wuce tun allura ta karshe
Hadari na musamman a yankunan cunkoson jama'a na Arewacin Najeriya
Idan an ga ciwon makogwaro tare da membrane mai toka-toka — a nemi likita nan take
Masu tafiya na dogon lokaci musamman a karkara: a yi la'akari da Tdap (tetanus, diphtheria, pertussis) booster
Ƙididdiga da bayanan yanki
Barkewar Najeriya 2022-2023 — mafi girma a tarihin baya-bayan nan:
17,000 shari'o'in da ake zargi, >600 mutuwa
Ta fara a Kano, ta bazu zuwa jihohi 20+
Yara 'yan shekaru 5–14 da ba a yi musu allura ba sun fi shafuwa
Jihohin da suka fi shafuwa: Kano, Katsina, Yobe, Lagos, Borno, Bauchi
Dalilan barkewar:
Karancin DPT3 coverage (~57% a Najeriya)
Cunkoson jama'a a birane
Rashin isassun kayan aikin lafiya da DAT
Sakaci a rigakafin yau da kullum na tsawon shekaru
A duniya: diphtheria ba ta yadu a kasashen da suka ci gaban rigakafi amma barkewar tana faruwa inda rigakafin ya yi kasa.
Wanene ke cikin haɗarin mafi girma
The risk of diphtheria is primarily determined by vaccination status and proximity to endemic or outbreak settings. The following factors increase the likelihood of infection and/or severe disease:
Risk factors for infection:
Incomplete or absent vaccination: The dominant risk factor globally. In the 1990s outbreak in the former Soviet Union (>150,000 cases, >5,000 deaths), the majority of cases occurred in adults whose childhood vaccine-induced immunity had waned without booster doses.
Living in or traveling to endemic areas: Regions with DTP3 coverage <80%, particularly sub-Saharan Africa, South Asia, and Southeast Asia
Crowded living conditions: Military barracks, refugee camps, prisons, homeless shelters — outbreaks propagate rapidly in overcrowded settings with poor hygiene
Close contact with a case or carrier: Household contacts of a diphtheria case have a secondary attack rate of 2–5% even in partially immunized populations
Low socioeconomic status and poor hygiene: Both respiratory and cutaneous diphtheria are diseases of poverty
Risk factors for severe disease and death:
Age: CFR is highest in children <5 years (up to 20%) and adults >40 years (up to 20–30%). The relatively lower CFR in older children and young adults (3–5%) reflects both immune maturity and lower membrane burden.
Delayed antitoxin administration: Every day of delay after day 2 of illness increases mortality. Antitoxin given on day 1 is associated with ~1% CFR; by day 4+, CFR exceeds 15%.
Extensive membrane: Membrane involving the larynx, trachea, or extending across the entire pharynx carries higher risk of airway obstruction and systemic toxicity.
Bull-neck (severe cervical edema): Indicates massive toxin production and correlates with higher rates of myocarditis and neuropathy.
Biotype: C. diphtheriae biotype gravis has historically been associated with more severe disease, though this correlation is not absolute.
Populations at increased risk in high-income countries:
Adults aged >50 years (waning immunity, inadequate booster uptake — serological studies show 30–60% are below protective antibody levels)
Immigrants and refugees from low-coverage countries
Homeless populations (cutaneous diphtheria)
Healthcare workers in contact with cases
Rikitarwa da za ta iya faruwa
Matsaloli — sun fi hatsari idan ba a ba da antitoxin da sauri ba:
Kumburin zuciya (Toxic myocarditis): Babban sanadin mutuwa. Yana bayyana kwanaki 10–14. ECG: block na zuciya, arrhythmias. A lokacin barkewar Najeriya, mutuwar kwatsam saboda matsalar zuciya ta faru a wasu yara da suke kamar sun warke.
Lalacewar jijiyoyi (Polyneuropathy): Gurguwar muƙamuƙi (mako 3–6), wahalar hadiya (hatsarin shaƙewa), raunin ƙafafu da hannaye (mako 6–10). Yawanci ana warkewa cikakke.
Toshewar hanyar numfashi: Membrane na iya toshe hanyar numfashi — mutuwa idan ba a yi tracheostomy ba
Cutar koda (Nephrotoxicity)
Mutuwa: 5–10% baki daya; ya fi girma idan ba a ba da antitoxin da wuri ba. A lokacin barkewar Najeriya 2022-2023: kashi na mutuwa ~3.6% (CFR) amma ya fi girma a yankunan da ba su da isassun kayan aikin lafiya.
Sakamakon da ake tsammani da murmurewa
Tare da antitoxin + maganin ƙwayoyin cuta: CFR 5–10%.
Ba tare da magani ba: CFR 30–50%.
Matsalolin da ke ƙayyade hasashen warkarwa:
Cutar zuciya (myocarditis): 10–25% na marasa lafiya, na iya kashe mutum. Na iya faruwa makonni 1–2 bayan farawa.
Lalacewar jijiyoyi: shanyen jijiyoyin kai (na bakin ciki, na ido), shanyen jijiyoyin waje (makonni 3–7 bayan farawa). Yawanci ana warke cikin makonni zuwa watanni.
Toshewar numfashi: daga ci gaban ƙarya-fata. Na iya buƙatar buɗe maƙogwaro.
Lalacewar ƙoda (ba kasafai ba).
Warkarwa: Tare da magani, mafi yawan marasa lafiya suna warke gaba ɗaya cikin makonni 4–6. Cutar zuciya na da mafi munin hasashen warkarwa.
Ana iya hana wannan cuta ta hanyar allurar rigakafi. Kariya mai inganci tana samuwa.
Yi magana da ƙwararren lafiyar tafiya game da jadawalin da aka ba da shawarar kafin tafiyar ku.
Nemo asibitin allurar rigakafi →Kun san allurar rigakafin da kuke bukata? Da kyau. Ba ku sani ba? Ku gaya mana inda kuke tafiya — za mu nemo allurar da ta dace da asibiti. Kyauta, ba tare da wani hakki ba.
Abun ciki a wannan shafin don bayani da ilimi ne kawai. Ba ya zama shawarar likita, gano cuta, ko shawarwarin magani ba. Idan kuna da damuwar lafiya, tuntuɓi ƙwararren ma’aikacin lafiya. SafeTripVax ba mai ba da sabis na likitanci ba ne.
Cikakkun sharuɗɗan amfaniRecent epidemiological data from the World Health Organization Global Health Observatory.
Source: WHO GHO OData ↗
And 13 more records
Source: WHO GHO OData ↗
This data is provided for informational purposes. Please consult official WHO sources for the most current information.
View WHO data source →